VIEW CART 0
You are here: Home > Compliance Rules&Regs
Choose a sub category:
Controlled Substances DEA DOT PART 40 RULES & REGS

DOT Final Rule Deadline October 1, 2010

August 16, 2010

The following is a summary of the Final Rule as written by the Director of Drug and Alcohol Policy and Compliance, Jim Swart:

  1. The Department is required by the Omnibus Transportation Employees Testing Act (Omnibus Act) to follow the HHS requirements for the testing procedures/protocols and drugs for which we test.
  2. Primary laboratory requirements in this final rule include:
    • - Testing for MDMA (aka. Ecstasy);
    • - Lowering cutoff levels for cocaine and amphetamines;
    • - Conducting mandatory initial testing for heroin;
  3. The Department brought several testing definitions in-line with those of HHS.
  4. Each Medical Review Officer (MRO) will need to be re-qualified – including passing an examination given by an MRO training organization - every five years. The Final Rule eliminated the requirement for each MRO to take 12 hours of continuing education every three years.
  5. An MRO will not need to be trained by an HHS-approved MRO training organization as long as the MRO meets DOT’s qualification and requalification training requirements.
  6. MRO recordkeeping requirements did not change from the five years for non-negatives and one year for negatives.
  7. The Final Rule does not allow the use of HHS-Certified Instrumented Initial Testing Facilities (IITFs) to conduct initial drug testing because the Omnibus Act requires laboratories to be able to perform both initial and confirmation testing but IITFs cannot conduct confirmation testing.

We highly recommend you review this document in its entirety and update your policy as needed. You can view the final rule directly from the DOT here.

PART 40 - PROCEDURES FOR TRANSPORTATION WORKPLACE DRUG AND ALCOHOL TESTING PROGRAMS
(Effective October 1, 2010) click here (must have adobe) to download the complete public file document.

Information provided by the Department of Transportation, Drug and Alcohol Policy and Compliance Office,
1200 New Jersey Avenue, SE, Washington, DC 20590 (202) 366-3784